PrairieView Partners LLC Has $629,000 Stake in Solventum Co. (NYSE:SOLV)

PrairieView Partners LLC boosted its holdings in Solventum Co. (NYSE:SOLV) by 3.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 9,530 shares of the company’s stock after acquiring an additional 334 shares during the period. PrairieView Partners LLC’s holdings in Solventum were worth $629,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in SOLV. Modus Advisors LLC acquired a new position in Solventum during the 4th quarter worth approximately $25,000. Copeland Capital Management LLC acquired a new position in Solventum in the 3rd quarter valued at approximately $26,000. Stonebridge Financial Group LLC acquired a new stake in shares of Solventum during the fourth quarter worth $26,000. Crews Bank & Trust acquired a new stake in shares of Solventum during the fourth quarter worth $32,000. Finally, True Wealth Design LLC increased its position in shares of Solventum by 23,550.0% during the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after buying an additional 471 shares during the period.

Solventum Price Performance

Shares of Solventum stock opened at $73.62 on Thursday. Solventum Co. has a 1 year low of $47.16 and a 1 year high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The company has a 50 day simple moving average of $70.51 and a two-hundred day simple moving average of $68.32.

Analysts Set New Price Targets

Several brokerages recently issued reports on SOLV. Morgan Stanley increased their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. Piper Sandler increased their target price on shares of Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, November 8th. Finally, Mizuho started coverage on shares of Solventum in a report on Wednesday, December 4th. They set a “neutral” rating and a $70.00 price objective for the company. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, Solventum currently has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.